689
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The Impact of Treatment Adherence on Quality of Life Among Type 2 Diabetes Mellitus Patients – Findings from a Cross-Sectional Study

ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, , , , , , & ORCID Icon show all
Pages 475-481 | Published online: 26 Feb 2021

References

  • Uk department of health. Long Term Conditions Compendium of Information Third Edition; 2020. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/216528/dh_134486.pdf. Accessed 05 October 2020.
  • Adriaanse MC, Drewes HW, Van Der Heide I, Struijs JN, Baan CA. The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients. Quality Life Res. 2016;25(1):175–182. doi:10.1007/s11136-015-1061-0
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
  • World Health Organization. Noncommunicable Diseases and Mental Health; 2020. Available from: https://www.who.int/mip/2003/progress/en/nmhmip2003.pdf. Accessed 5 November, 2020.
  • Jackevicius CA. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–467. doi:10.1001/jama.288.4.462
  • Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160(1):31–37.
  • Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880–2883. doi:10.1001/jama.288.22.2880
  • Khayyat SM, Mohamed MMA, Khayyat SMS, et al. Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey. Quality Life Res. 2019;28(4):1053–1061. doi:10.1007/s11136-018-2060-8
  • Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: a diagnosable and treatable medical condition. JAMA. 2013;309(20):2105–2106. doi:10.1001/jama.2013.4638
  • Choudry MI, Stewart K, Woodhead T. The Royal College of Physician’s Quality Improvement Hub – how can it help physicians to improve patient care? Future Hospital J. 2016;3(3):211–216. doi:10.7861/futurehosp.3-3-211
  • Davis MV, Mahanna E, Joly B, et al. Creating quality improvement culture in public health agencies. Am J Public Health. 2014;104(1):e98–104. doi:10.2105/ajph.2013.301413
  • Porterfield DS, Marcial LH, Brown S, Throop C, Pina J. Evaluation of a Quality Improvement Resource for Public Health Practitioners. Public Health Rep. 2017;132(2):140–148. doi:10.1177/0033354916689609
  • Martin JC, Avant RF, Bowman MA, et al. The Future of Family Medicine: a collaborative project of the family medicine community. Ann Fam Med. 2004;2 Suppl 1(Suppl 1):S3–32. doi:10.1370/afm.130
  • World Health Organization. Diabetic country profile; 2020. Available from: https://www.who.int/diabetes/country-profiles/pak_en.pdf. Accessed 5 November, 2020.
  • Sherin A. National diabetes action plan of Pakistan: need and challenges. Khyber Med Univ J. 2015;7(1):1–2.
  • Nazir R, Hassali MA, Saleem F, Bashir S, Aljadhey H. Does adherence to the therapeutic regimen associate with health related quality of life: findings from an observational study of type 2 diabetes mellitus patients in Pakistan. Pak J Pharm Sci. 2017;30(6):2159–2165.
  • International Diabetic Federation. IDF DIABETES ATLAS 9th Edition. 9th ed. 2019.
  • Raosoft I. Sample size calculator; 2004. Available From: http://www.raosoft.com/samplesize.html. Accessed 15 February, 2021
  • Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13(1):177–183. doi:10.1017/S0033291700050182
  • Saleem F, Hassali MA, Shafie AA, Awad AG, Bashir S. Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan. Tropical J Pharm Res. 2011;10:2.
  • Euqator Group. EQ-5D-5L; 2020. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/. Accessed 05 November 2020.
  • Dolan P, Gudex C, Kind P, Williams A. A Social Tariff for EuroQol: Results from a UK General Population Survey. 1995.
  • Bassett SM, Schuette SA, O’Dwyer LC, Moskowitz JT. Positive affect and medication adherence in chronic conditions: a systematic review. Health Psychol. 2019;38(11):960. doi:10.1037/hea0000778
  • Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Preference Adherence. 2016;10:1299. doi:10.2147/PPA.S106821
  • Boccuzzi SJ, Wogen J, Fox J, Sung JC, Shah AB, Kim J. Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care. 2001;24(8):1411–1415. doi:10.2337/diacare.24.8.1411
  • Perwitasari DA, Urbayatun S. Treatment adherence and quality of life in diabetes mellitus patients in Indonesia. Sage Open. 2016;6(2):2158244016643748. doi:10.1177/2158244016643748
  • Shao H, Chen G, Zhu C, et al. Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus. Patient Preference Adherence. 2017;11:897. doi:10.2147/PPA.S92533
  • Saleh F, Mumu SJ, Ara F, Hafez MA, Ali L. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC Public Health. 2014;14(1):431. doi:10.1186/1471-2458-14-431
  • Ueno H, Ishikawa H, Suzuki R, et al. The association between health literacy levels and patient-reported outcomes in Japanese type 2 diabetic patients. SAGE Open Med. 2019;7:2050312119865647. doi:10.1177/2050312119865647
  • Rodrigues da Rocha M, Domingas dos Santos S, Rafaela de Moura K,de Sousa Carvalho L, Holanda de Moura I, Vilarouca da Silva AR. Health literacy and adherence to drug treatment of type 2 diabetes mellitus. Escola Anna Nery. 2019;23:2.
  • Amelia R, Lelo A, Lindarto D, Mutiara E. Quality of life and glycemic profile of type 2 diabetes mellitus patients of Indonesian: a descriptive study. InIOP Conf Series. 2018. doi:10.1088/1755-1315/125/1/012171
  • Lam CL, Lauder IJ. The impact of chronic diseases on the health-related quality of life (HRQOL) of Chinese patients in primary care. Fam Pract. 2000;17(2):159–166. doi:10.1093/fampra/17.2.159
  • Azar FF, Solhi M, Chabaksvar F. Investigation of the quality of life of patients with hypertension in health centers. J Educ Health Promot. 2020;9(1):185. doi:10.4103/jehp.jehp_741_19
  • ElShazly HM, Hegazy NN. Socioeconomic determinants affecting the quality of life among diabetic and hypertensive patients in a rural area, Egypt. J Family Med Prim Care. 2017;6(1):141–145. doi:10.4103/jfmpc.jfmpc_31_17
  • Saleem F, Hassali MA, Shafie AA. A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expect. 2014;17(3):388–395. doi:10.1111/j.1369-7625.2012.00765.x
  • Iqbal Q, Ul Haq N, Bashir S, Bashaar M. ul Haq N, Bashir S, Bashaar M. Profile and predictors of health related quality of life among type II diabetes mellitus patients in Quetta city, Pakistan. Health Qual Life Outcomes. 2017;15(1):142. doi:10.1186/s12955-017-0717-6
  • Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proc. 2011;86(4):304–314. doi:10.4065/mcp.2010.0575